Nutex Health Inc.

NUTX

Nutex Health Inc.

NUTX

Insider Sentiment (TTM):

Last Purchase:2026-03-20Last Sale:-Shares Purchased (TTM):1,241Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:2,716,157Shares Outstanding:6,989,828Institutional Ownership Pct.:38.86%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Nonrelated Party	-	340	319	38	54	295	232	-	-	-	59	-
Related Party	-	340	319	38	54	295	232	-	-	-	59	-
Assets
Cash And Cash Equivalents At Carrying Value	205	207	186	166	97	88	41	47	41	30	22	27
Accounts Receivable Net Current	-	-	-	-	-	295	232	63	61	62	59	53
Accounts And Other Receivables Net Current	-	-	-	-	-	4	4	4	5	4	4	1
Assets Current
Assets Current	586	580	539	593	473	402	292	120	114	100	91	90
Restricted Cash Current	2	3	0	-	-	-	0	-	-	-	-	-
Restricted Investments Current	-	-	0	0	0	3	3	-	-	-	0	-
Inventory Net	4	5	3	3	2	3	3	2	3	3	3	3
Income Taxes Receivable	-	-	-	12	-	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	18	18	25	17	19	11	10	4	5	2	3	6
Property Plant And Equipment Net	96	95	95	83	83	76	78	78	79	78	81	85
Operating Lease Right Of Use Asset	26	27	27	27	28	27	28	11	12	12	12	17
Finance Lease Right Of Use Asset	-	221	222	226	215	216	219	198	187	174	176	248
Intangible Assets Net Excluding Goodwill	21	21	21	22	15	15	16	16	16	20	21	22
Goodwill	14	14	14	14	14	14	14	14	14	17	17	18
Deferred Income Tax Assets Net	-	-	0	0	13	10	8	-	-	-	0	-
Other Assets	-	-	-	-	-	1	1	1	1	1	0	0
Other Assets Noncurrent	4	1	1	0	0	-	1	-	-	-	-	-
Assets	965	957	919	965	841	762	655	438	422	404	398	480
Liabilities And Stockhold…
Accounts Payable Current	-	-	-	-	-	20	10	10	17	17	19	18
Lines Of Credit Current	0	0	1	5	8	7	4	3	3	3	3	3
Liabilities Current
Liabilities Current	117	184	158	185	195	196	154	68	72	60	58	67
Long Term Debt Current	8	17	13	18	19	14	14	10	14	9	11	20
Operating Lease Liability Current	2	2	2	2	2	2	2	2	2	2	2	2
Other Accrued Liabilities Current	-	-	2	-	-	25	2	30	23	18	13	15
Finance Lease Liability Current	-	7	7	7	7	8	8	5	6	4	4	4
Litigation Reserve Current	50	57	50	64	69	52	48	-	-	-	0	-
Taxes Payable Current	-	16	1	0	8	46	27	-	-	-	0	-
Deferred Compensation Share Based Arrangements Lia…	5	3	8	11	24	21	16	-	-	-	0	-
Long Term Debt Noncurrent	31	24	29	26	20	22	22	27	22	26	26	19
Operating Lease Liability Noncurrent	29	30	30	30	31	30	31	14	15	15	15	16
Finance Lease Liability Noncurrent	-	269	269	270	258	258	259	241	227	213	214	264
Deferred Income Tax Liabilities Net	11	8	9	15	-	-	0	3	3	5	5	8
Liabilities	457	515	495	526	504	507	467	359	340	324	319	375
Stockholders Equity Inclu…
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	568	586	616	615	589	513	489	479	473	472	471	467
Retained Earnings Accumulated Deficit	-174	-239	-286	-298	-353	-336	-357	-419	-410	-409	-409	-377
Stockholders Equity	394	442	329	438	337	177	132	80	82	80	79	105
Minority Interest	113	96	94	121	102	78	56	19	19	17	18	15
Liabilities And Stockholders Equity	965	957	919	965	841	762	655	438	422	404	398	480
Accumulated Depreciation Depletion And Amortizatio…	-35	-34	-32	-	-	-	-25	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	950	950	950	950	950	950	950	950	950	950	950	950
Common Stock Shares Issued	7	7	7	7	7	6	6	5	5	50	5	671
Shares Outstanding	7	7	7	7	7	6	6	5	5	5	5	4

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-0.24%	26.27%	36.73%	-	-	-	-	-	-	-	-	-
2025	-3.10%	-6.00%	-33.30%	86.38%	87.68%	0.71%	64.80%	65.95%	-10.95%	-10.95%	2.75%	12.88%
2024	3.48%	-9.85%	18.79%	170.76%	146.84%	207.47%	28.76%	10.25%	47.25%	162.68%	240.10%	142.16%
2023	-	-	-	-19.71%	-41.16%	-47.25%	-17.60%	-28.00%	-45.20%	-	-	-
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	5.00	3.14	3.41	3.20	2.43	2.05	1.90	1.77	1.59	1.68	1.56	1.34
Quick Ratio	4.81	3.02	3.24	3.09	2.32	1.97	1.81	1.68	1.48	1.60	1.45	1.21
Working Capital	468.43M	395.21M	380.90M	407.20M	278.15M	205.34M	138.25M	52.24M	42.21M	40.47M	32.54M	22.59M
Leverage & Debt
Debt to Equity	0.90	1.17	1.17	1.20	1.50	1.98	2.48	4.50	4.15	4.05	4.03	3.57
Interest Coverage TTM	18.42	13.29	12.40	16.10	10.72	9.71	6.56	-0.51	-1.13	-1.47	-1.95	-0.76
Debt Ratio	0.47	0.54	0.54	0.55	0.60	0.66	0.71	0.82	0.81	0.80	0.80	0.78
Efficiency & Turnover
Asset Turnover TTM	0.94	1.02	1.11	1.40	1.25	1.07	0.91	0.64	0.64	0.62	0.60	0.51
Days Sales Outstanding TTM	-	-	-	-	-	104.25	110.68	72.47	73.64	79.35	85.78	90.33
Receivables Turnover TTM	-	-	-	-	-	3.50	3.30	5.04	4.96	4.60	4.26	4.04
Per Share Metrics
Diluted EPS TTM	43.63	26.79	26.70	20.22	13.77	16.01	9.49	-6.12	-5.95	-7.60	-9.85	-5.53
Free Cash Flow Per Share TTM	39.90	38.49	38.61	26.31	13.88	12.25	4.10	3.80	2.90	0.36	0.11	1.53
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	51.26%	47.47%	50.76%	55.01%	51.35%	48.77%	40.89%	23.24%	19.21%	15.49%	14.04%	7.87%
Operating Profit Margin TTM	43.02%	31.39%	31.49%	36.59%	30.08%	33.62%	27.23%	-3.33%	-7.33%	-10.00%	-12.83%	-4.92%
Net Profit Margin TTM	36.18%	21.86%	20.61%	14.79%	10.42%	16.54%	10.85%	-10.69%	-10.72%	-14.25%	-17.53%	-10.59%
Growth Metrics
Net Revenue Growth (1Y)	6.88%	40.95%	82.36%	236.03%	187.10%	141.25%	93.80%	26.02%	39.80%	31.69%	12.93%	-26.28%
Net Income Growth (1Y)	271.04%	86.23%	246.19%	-565.08%	-379.02%	-380.12%	-219.97%	27.22%	-93.30%	-91.92%	-89.78%	-92.95%
EPS Growth (1Y)	223.74%	50.99%	177.05%	-453.95%	-331.30%	-339.69%	-203.89%	10.59%	-94.10%	-27.74%	-90.19%	932.51%
Valuation Metrics
P/E TTM	3.83	3.45	5.81	4.77	9.04	2.58	3.10	-3.55	-1.00	-1.89	-2.74	-5.50
P/B TTM	2.31	1.50	2.47	1.58	2.22	1.04	0.86	1.39	0.36	0.87	1.50	1.29
P/S TTM	1.39	0.75	1.20	0.71	0.94	0.43	0.34	0.38	0.11	0.27	0.48	0.58
Market Cap	1.17B	664.31M	1.05B	692.37M	746.31M	266.52M	161.33M	110.67M	29.57M	69.83M	119.02M	135.01M
Enterprise Value	1.01B	505.47M	911.67M	582.31M	703.92M	232.31M	168.81M	109.71M	33.87M	82.66M	141.83M	154.67M
Calculated Values
Free Cash Flow TTM	274.17M	269.02M	245.60M	176.28M	83.24M	69.43M	20.85M	19.37M	14.43M	1.74M	472.67K	6.79M
Net Debt	-165.51M	-158.85M	-135.54M	-110.06M	-42.39M	-34.21M	7.48M	-961.96K	4.30M	12.83M	22.81M	19.66M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-20Purchase

Owner: Jaumot, Frank E

Title: -

Shares: 150

Price/Share: $93.56

Value: $14,034.00

Shares Owned: 150

Relationship: Director

Ownership: Direct

2026-03-19Purchase

Owner: Hosseinion, Warren

Title: President

Shares: 252

Price/Share: $94.07

Value: $23,705.64

Shares Owned: 7,765

Relationship: Director,Officer

Ownership: Direct

2026-03-17Purchase

Owner: Spears, Kelvin

Title: -

Shares: 10

Price/Share: $94.46

Value: $944.60

Shares Owned: 32,137

Relationship: Director

Ownership: Direct

2026-03-13Purchase

Owner: Montgomery, Pamela W.

Title: Chief Legal Officer-Healthcare

Shares: 79

Price/Share: $88.87

Value: $7,020.73

Shares Owned: 2,758

Relationship: Officer

Ownership: Direct

2025-11-25Purchase

Owner: Bates, Jon Christian

Title: Chief Financial Officer

Shares: 750

Price/Share: $136.71

Value: $102,532.50

Shares Owned: 5,638

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-20	Jaumot, Frank E	Director	-	Direct	Purchase	150	93.56	$14,034.00	150	4
2026-03-19	Hosseinion, Warren	Director,Officer	President	Direct	Purchase	252	94.07	$23,705.64	7,765	4
2026-03-17	Spears, Kelvin	Director	-	Direct	Purchase	10	94.46	$944.60	32,137	4
2026-03-13	Montgomery, Pamela W.	Officer	Chief Legal Officer-Healthcare	Direct	Purchase	79	88.87	$7,020.73	2,758	4
2025-11-25	Bates, Jon Christian	Officer	Chief Financial Officer	Direct	Purchase	750	136.71	$102,532.50	5,638	4
2025-04-08	Bates, Jon Christian	Officer	Chief Financial Officer	Direct	Purchase	1,000	81.81	$81,810.00	4,888	4
2024-08-22	Bates, Jon Christian	Officer	Chief Financial Officer	Direct	Purchase	1,350	21.46	$28,971.00	2,277	4
2024-08-20	Detillio, Joshua	Officer	Chief Operating Officer	Direct	Purchase	575	17.40	$10,005.00	4,808	4
2024-06-12	Detillio, Joshua	Officer	Chief Operating Officer	Direct	Purchase	20,000	0.54	$10,800.00	29,333	4
2024-05-30	Vo, Thomas T.	Director,Officer	Chief Executive Officer	Indirect	Purchase	2,986	0.66	$1,970.76	18,060,663	4
2023-11-20	Vo, Thomas T.	Director,Officer	Chief Executive Officer	Indirect	Purchase	275,200	0.23	$63,296.00	269,822,776	4
2023-11-15	Detillio, Joshua	Officer	Chief Operating Officer	Direct	Purchase	140,000	0.24	$33,600.00	140,000	4
2023-08-31	Vo, Thomas T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Indirect	Purchase	152,326	0.28	$42,651.28	269,322,776	4
2023-06-15	Bates, Jon Christian	Officer	Chief Financial Officer	Direct	Purchase	20,000	0.42	$8,400.00	89,505	4
2023-06-14	Montgomery, Pamela W.	Officer	Chief Legal Officer	Direct	Purchase	12,000	0.43	$5,160.00	28,502	4
2023-06-14	Creem, Mitchell	Director	-	Indirect	Purchase	50,000	0.43	$21,500.00	81,746	4
2023-06-13	Reed, Michael Lee	Director	-	Indirect	Purchase	10,000	0.43	$4,300.00	10,000	4
2023-06-13	Grenas, Cheryl Yvonne	Director	-	Indirect	Purchase	10,000	0.43	$4,300.00	10,000	4
2023-05-26	Vo, Thomas T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Indirect	Purchase	18,028	0.49	$8,833.72	268,322,776	4
2023-05-18	Waters, John J	Director	-	Direct	Purchase	50,000	0.47	$23,500.00	196,262	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

38.86%

Inst. Shares: 2,716,157

Shares Outstanding: 6,989,828

2025-12-31

40.40%

Inst. Shares: 2,570,140

Shares Outstanding: 6,361,427

2025-09-30

35.87%

Inst. Shares: 2,404,067

Shares Outstanding: 6,701,240

2025-06-30

28.39%

Inst. Shares: 1,701,896

Shares Outstanding: 5,994,933

2025-03-31

17.73%

Inst. Shares: 1,004,823

Shares Outstanding: 5,667,076

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	2,716,157	6,989,828	38.86%
2025-12-31	2,570,140	6,361,427	40.40%
2025-09-30	2,404,067	6,701,240	35.87%
2025-06-30	1,701,896	5,994,933	28.39%
2025-03-31	1,004,823	5,667,076	17.73%
2024-12-31	906,644	5,090,787	17.81%
2024-09-30	452,246	5,100,030	8.87%
2024-06-30	2,783,633	4,969,726	56.01%
2024-03-31	73,473,522	4,849,235	-
2023-12-31	34,566,681	4,408,320	-
2023-09-30	34,219,245	4,433,704	-
2023-06-30	29,100,209	4,377,088	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Nutex Health Inc. (NUTX) — SEC Financial Statements & Analysis

Nutex Health Inc. (NUTX) is a services-business services, nec company, incorporated in DE. Nutex Health Inc. trades on Nasdaq as: NUTX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Nutex Health Inc. reported a 6.88% year-over-year revenue growth, a Gross Profit Margin of 51.26% (TTM), a Debt-to-Equity ratio of 0.90x, a Price-to-Sales (P/S) ratio of 1.39x (TTM), a Price-to-Book (P/B) ratio of 2.31x (TTM), at a market cap of $1.17B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 6.88%
Gross Profit Margin TTM: 51.26%
Debt To Equity: 0.90x
P/S TTM: 1.39x
P/B TTM: 2.31x
Market Cap: $1.17B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Nutex Health Inc. in?

Nutex Health Inc. (NUTX) operates in the Services-Business Services, NEC industry.

What is NUTX's market cap?

Nutex Health Inc. (NUTX) has a market capitalization of $1.17B as of 2026-06-30.

What is NUTX's P/E ratio?

Nutex Health Inc. (NUTX)'s trailing twelve month P/E ratio is 3.83x as of 2026-06-30.

What exchange does NUTX trade on?

Nutex Health Inc. (NUTX) trades on the Nasdaq.

Where is Nutex Health Inc. incorporated?

Nutex Health Inc. is incorporated in DE.

Nutex Health Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Nutex Health Inc. (NUTX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Business Services, NEC

Wall Street's data.
Main Street's price.

Nutex Health Inc. (NUTX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Business Services, NEC

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.